P Stougianos Selected Research

Fibrinogen (Factor I)

1/2012

Clinical utility of biomarkers in premature atherosclerosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

P Stougianos Research Topics

Disease

1	Necrosis 01/2012
1	Atherosclerosis 01/2012

Drug/Important Bio-Agent (IBA)

1	N,N-dimethylarginine (asymmetric dimethylarginine)IBA 01/2012
1	ApolipoproteinsIBA 01/2012
1	C-Reactive ProteinIBA 01/2012
1	CathepsinsIBA 01/2012
1	Fibrinogen (Factor I)FDA Link 01/2012
1	HomocysteineIBA 01/2012
1	InterleukinsIBA 01/2012
1	Lipoproteins (Lipoprotein)IBA 01/2012
1	Peroxidase (Myeloperoxidase)IBA 01/2012
1	Phospholipases (Phospholipase)IBA 01/2012
1	Biomarkers (Surrogate Marker)IBA 01/2012
1	Cystatin CIBA 01/2012